Category Archive: Healthcare

A “LOWBALL OPENING” – SHIRE’S TAKEOVER OFFER FOR BAXALTA

by

Shire made a $30bn (£19bn) hostile takeover bid for Baxalta. Industry overview Shire is a London-listed drug company, with tax domicile in Ireland and Jersey. Shire develops and provides healthcare in the areas of behavioral… Continue reading

GENERICALLY SPEAKING, HEALTHCARE M&A IS ON FIRE

by

Industry Overview During the past weeks we observed a lot of activity in the healthcare sector centering around three companies: Mylan, Perrigo and Teva. Mylan is a Dutch pharmaceutical company headquartered in Amsterdam.… Continue reading

THE END OF A TRILOGY – VALEANT ON SALIX CASE.

by

The increased M&A activity within the Healthcare sector has not slowed down in 2015, after we saw a record volume of transactions in the previous year. After securing financing, Canada-based Valeant has won… Continue reading

GLAXOSMITHKLINE & NOVARTIS SWAP ASSTES WORTH £11BN

by

The asset-swap between GlaxoSmithKline (NYSE: GSK) and Novartis (NYSE: NVS) will lead to stronger focus by both companies on their current core activities. The transaction sets a new framework for future complex deals,… Continue reading

ACTAVIS ACQUIRES BOTOX-MAKER ALLERGAN FOR $66BN

by

The acquisition of Allergan Inc. (NYSE:AGN) by Actavis Plc. (NYSE:ACT) will lead to the creation of one of the biggest pharmaceutical companies in the world. The $66bn deal is expected to be closed… Continue reading